A preliminary study analyzing HIF-1α levels in tumor specimens showed that HIF-1α levels were elevated in 69% of metastatic breast cancers, while only 29% of primary breast cancers exhibited elevations in HIF-1α levels125. This evidence concerns the gene HIF1A and breast carcinoma.